Labcorp (LH)
Provides clinical diagnostics and global laboratory support for biopharma research.
$311.54
After hours+0.15 (+0.05%)
At close$311.39(−2.99%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 97.53% | 79.97M shares | |
|---|---|---|---|
| 1,070 holders · as of Jun 30, 2026 | |||
| Insiders | 0.38% | 313.9K shares | |
| 24 holders · as of Aug 18, 2026 | |||
| Other | 2.09% | 1.71M shares | |
| remainder | |||
82.00M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
1,070 holders · 79.97M shares · 111 new positions · 467 increased · 394 reduced · 85 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.57M | 8.02% | +129.4K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 5.36M | 6.54% | −13.9K | Aug 13, 2026 |
| Victory Capital Management Inc | 4.84M | 5.90% | +210.4K | Aug 7, 2026 |
| State Street Corp | 3.91M | 4.77% | +44.5K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 3.68M | 4.49% | −1.9K | Aug 13, 2026 |
| Boston Partners | 3.05M | 3.72% | +682.9K | Aug 4, 2026 |
| Allspring Global Investments Holdings, LLC | 2.24M | 2.73% | +10.5K | Aug 13, 2026 |
| Geode Capital Management, LLC | 2.19M | 2.67% | +2.9K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.60% | 6.33M | 13G | Apr 24, 2025 |
| Vanguard Capital Management | 7.52% | 6.20M | 13G | Apr 28, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Kerrii B. Andersondirector | Sale | 3,000 | $318.02 | 6,563 |
| Aug 11, 2026 | Adam H. Schechterdirector, officer: President & CEO | Sale | 4,669 | $320.37 | 102,565 |
| Aug 4, 2026 | Amy B. Summyofficer: EVP, Chief Marketing Officer | Sale | 924 | $306.74 | 6,956 |
| Aug 3, 2026 | Peter J. Wilkinsonofficer: SVP, Chief Accounting Officer | Sale · 2 lots | 1,420 | $309.23 | 1,770 |
| Jul 2, 2026 | Bryan T. Vaughnofficer: EVP and President, Diagnostics | Sale | 234 | $286.19 | 6,746 |
| Jul 2, 2026 | Kathryn W. Kyleofficer: EVP, Chief Legal Officer | Sale | 92 | $286.19 | 3,904 |
| Jun 8, 2026 | Kathryn W. Kyleofficer: EVP, Chief Legal Officer | Sale | 762 | $263.89 | 3,813 |
| May 11, 2026 | Adam H. Schechterdirector, officer: President & CEO | Sale | 5,903 | $254.50 | 107,234 |
| Mar 27, 2026 | Jonathan C. Meltzerofficer: EVP, Operations | Sale | 839 | $267.05 | 3,620 |
| Mar 27, 2026 | Peter J. Wilkinsonofficer: SVP, Chief Accounting Officer | Sale | 1,633 | $267.05 | 1,852 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. April Delaney · MD06 | Sale | $100,001 – $250,000 | Aug 25, 2026 | Sep 10, 2026 | |
| Rep. April Delaney · MD06 | Sale | $1,001 – $15,000 | Aug 7, 2026 | Sep 10, 2026 | |
| Rep. April Delaney · MD06 | Sale | $1,001 – $15,000 | Aug 6, 2026 | Sep 10, 2026 | |
| Rep. April Delaney · MD06 | Sale | $1,001 – $15,000 | Aug 5, 2026 | Sep 10, 2026 |